We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
-3.76%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$140B
AUM Growth
-$7.99B
Cap. Flow
-$367M
Cap. Flow %
-0.26%
Top 10 Hldgs %
25.82%
Holding
2,744
New
4
Increased
1,361
Reduced
727
Closed
30

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
DRE
Duke Realty Corp.
DRE
+$91.2M
3
CVX icon
Chevron
CVX
+$54.7M
4
CTXS
Citrix Systems Inc
CTXS
+$52.9M
5
MSFT icon
Microsoft
MSFT
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 26.12%
2 Healthcare 15.83%
3 Consumer Discretionary 12.65%
4 Industrials 8.88%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRLD icon
2426
World Acceptance Corp
WRLD
$884M
$794K ﹤0.01%
8,200
-300
-4% -$34.7K
ALBO
2427
DELISTED
Albireo Pharma Inc
ALBO
$792K ﹤0.01%
40,900
GEF.B icon
2428
Greif Class B
GEF.B
$4.24B
$790K ﹤0.01%
13,000
FRPH icon
2429
FRP Holdings
FRPH
$425M
$788K ﹤0.01%
29,000
ALGT icon
2430
Allegiant Air
ALGT
$2.31B
$783K ﹤0.01%
10,728
TGB
2431
Trekor Metals
TGB
$3.2B
$783K ﹤0.01%
679,200
TPB icon
2432
Turning Point Brands
TPB
$1.73B
$783K ﹤0.01%
36,900
GDRX icon
2433
GoodRx Holdings
GDRX
$1.22B
$778K ﹤0.01%
166,700
-5,900
-3% -$37.2K
ICPT
2434
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$776K ﹤0.01%
55,600
MLNK
2435
DELISTED
MeridianLink
MLNK
$775K ﹤0.01%
47,600
SFIX
2436
Stitch Fix
SFIX
$474M
$775K ﹤0.01%
196,300
AVPT icon
2437
AvePoint
AVPT
$2.75B
$774K ﹤0.01%
193,100
DYN icon
2438
Dyne Therapeutics
DYN
$4.89B
$772K ﹤0.01%
60,800
OFLX icon
2439
Omega Flex
OFLX
$304M
$769K ﹤0.01%
8,300
WSBF icon
2440
Waterstone Financial
WSBF
$378M
$769K ﹤0.01%
47,600
-2,500
-5% -$43.9K
CBL
2441
CBL Properties
CBL
$1.77B
$768K ﹤0.01%
30,000
CLAR icon
2442
Clarus
CLAR
$141M
$766K ﹤0.01%
56,900
HYLN icon
2443
Hyliion Holdings
HYLN
$694M
$761K ﹤0.01%
265,300
CDLX icon
2444
Cardlytics
CDLX
$24.7M
$760K ﹤0.01%
8,090
+220
+3% +$31.3K
EVCM icon
2445
EverCommerce
EVCM
$1.76B
$754K ﹤0.01%
69,000
CRDO icon
2446
Credo Technology Group
CRDO
$50B
$750K ﹤0.01%
68,200
CIR
2447
DELISTED
CIRCOR International, Inc
CIR
$748K ﹤0.01%
45,350
SRG
2448
Seritage Growth Properties
SRG
$131M
$742K ﹤0.01%
82,238
CNSL
2449
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$740K ﹤0.01%
177,847
+38,200
+27% +$236K
EGRX
2450
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$740K ﹤0.01%
28,000

Similar funds

Swiss National Bank's Q3 2022 Portfolio in Review

As of Q3 2022, Swiss National Bank held 2,744 positions worth $140B, down 5.4% from $148B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 1.2%. Swiss National Bank opened 4 new positions and exited 30, leaving the 2,744-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q3 2022 buy was Northrop Grumman: 639,945 shares worth $301M.
  • Swiss National Bank added most to Prologis in Q3 2022, an estimated $97.9M increase.
  • Swiss National Bank's biggest Q3 2022 reduction was Apple, cutting an estimated $102M.
  • Swiss National Bank fully exited Duke Realty Corp. in Q3 2022, selling an estimated $91.2M.
  • Swiss National Bank's ten largest holdings make up 26% of its $140B portfolio in Q3 2022.
  • Swiss National Bank opened 4 new positions and closed 30 in Q3 2022.
  • Swiss National Bank's portfolio value fell 5.4% quarter-over-quarter to $140B.

Based on Swiss National Bank's 13F filing for Q3 2022, filed 9 Nov 2022.